SANS PRĖCĖDENT - TWO LEGENDS EXPLORE ONE OF THE WORLD'S MOST RESPECTED VARIETALS
SANY Group Makes Historic Debut on the 2025 World's Top 500 Brands List
ZK International Postpones Shareholder Call
Grey/Ven Appoints Ilana Kugel as Creative Director for Womenswear
'The convergence between of AI and the Biology' LG Creates "Next-Generation Protein Structure Prediction AI" for Drug Discovery
Yaber's Valentine's Day Gift Guide: Share Love with the Perfect Projector
SKF continues the preparations for the separation of its Automotive business; initiates consent solicitation
Babies Bliss Singapore: Holistic Support for Couples Trying to Conceive During the Festive Season
Bowtie Collaborate with Gleneagles Hospital Hong Kong and Pfizer Hong Kong to Promote Health Education
GCCL Wins 2025 Asia-Pacific Customer Value Leadership Award by Frost & Sullivan
-
Nuance Pharma Announces Approval of Ohtuvayre™ (ensifentrine) in Macau SAR, China
Ohtuvayre™is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients First inhaled COPD treatment providing bronchodilation and non-steroidal anti-inflammatory effects SHANGHAI, Feb. 7, 2025 /PRNewswire/ -- Today, Nuance Pharma ("Nuance") announced that the Pharmaceutical Administration Bureau Macau approved Ohtuvayre™ (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients. In June 2024, Ohtuvayre™ was approved in the United States and became commercially available in August. Ohtuvayre™ is a first-in-class selective dual inhibitor of phosphodiesterase 3 and 4 ("PDE3; PDE4") that combines bronchodilator and non-steroidal anti-inflammatory effects in one molecule, delivered directly to the lungs through a standard jet nebulizer without the need for high inspiratory flow rates or complex hand-breath coordination. The approval of Ohtuvayre™ in Macau SAR, China, was based on extensive data including the Global Phase 3 ENHANCE trials, the results of which were published in the American Journal of Respiratory and Critical Care Medicine. In the ENHANCE trials, OhtuvayreTM demonstrated clinical benefits both alone and when used with other maintenance therapies. OhtuvayreTM was well-tolerated in a broad population of subjects with moderate to severe COPD. Mark Lotter, founder and Chief Executive Officer of Nuance Pharma, said: "We are pleased to announce that the Macau regulatory authority has approved the NDA of Ohtuvayre™, which also marks the first regulatory approval outside of the US. We are proud to provide access to this highly innovative COPD treatment to patients in Macau and beyond, for example through innovative policy in the Greater Bay Area (GBA). Respiratory disease is among Nuance's core areas of focus, and through approval in Macao SAR and early access programs in Hainan BoAo and GBA, Nuance Pharma is looking forward to providing this novel, first-in-class treatment to patients in China, prior to our expected NDA submission in 2025 upon completion of the ENHANCE-CHINA trial." David Zaccardelli, Pharm. D., President and Chief Executive Officer of Verona Pharma, said: "We are very pleased that OhtuvayreTM is available to help patients still experiencing daily COPD symptoms. We are encouraged by the initial impact of OhtuvayreTM and believe its novel profile can re-define the COPD treatment paradigm." In Nov 2024, Nuance Pharma launched Ohtuvayre™ in China's Hainan Boao Pilot Zone through early access program. In Sep 2024, Nuance Pharma completed recruitment for ENHANCE-CHINA, the phase 3 clinical trial of ensifentrine for the maintenance treatment of COPD. In 2021, Nuance Pharma entered into an agreement with Verona Pharma for the exclusive rights to develop and commercialize Ohtuvayre™ in Greater China (mainland China, Hong Kong, Macau and Taiwan). About Ohtuvayre™ (ensifentrine) Ohtuvayre™ is the first inhaled therapy for the maintenance treatment of COPD that combines bronchodilator and non-steroidal anti-inflammatory activities in one molecule. Verona has evaluated nebulized Ohtuvayre™ in its Phase 3 clinical program ENHANCE ("Ensifentrine as a Novel inHAled Nebulized COPD thErapy") for COPD maintenance treatment. Ohtuvayre™ met the primary endpoint in both ENHANCE-1 and ENHANCE-2, demonstrating statistically significant and clinically meaningful improvements in lung function. About Verona Pharma Verona Pharma is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of chronic respiratory diseases with significant unmet medical needs. OhtuvayreTM (ensifentrine) is the Company's first commercial product and the first inhaled therapy for the maintenance treatment of COPD that combines bronchodilator and non-steroidal anti-inflammatory activities in one molecule. Ensifentrine has potential applications in non-cystic fibrosis bronchiectasis, cystic fibrosis, asthma and other respiratory diseases. For more information, please visit www.veronapharma.com. About Nuance Pharma Nuance Pharma is an innovation focused biopharmaceutical company, with both late-stage clinical pipeline and commercial stage asset portfolio. Focusing on specialty care, Nuance has established a differentiated combination of commercialized assets and innovative pipeline across respiratory, pain management, emergency care and iron deficiency anemia. With the mission to address critical unmet medical needs in Asia Pacific, Nuance deploys the Dual Wheel model that develops a global leading innovative pipeline, while maintaining a self-sustainable commercial operation in both China and Asia as a region. For more information, please visit www.nuancepharma.com. Forward-looking Statements This news release may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the Company or its officers with respect to the business operations and financial condition of the Company, which can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident" and similar statements. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, or other factors, some of which are beyond the control of the Company and are unforeseeable. Therefore, the actual results may differ from those in the forward-looking statements as a result of various factors and assumptions, such as future changes and developments in our business, competitive environment, political, economic, legal and social conditions. The Company or any of its affiliates, directors, officers, advisors or representatives has no obligation and does not undertake to revise forward-looking statements to reflect new information, future events or circumstances after the date of this news release, except as required by law.
-
NZ Safety Blackwoods Cuts Annual Cycle Count Time by 50% with Manhattan SCALE™
SYDNEY, Feb. 7, 2025 /PRNewswire/ -- NZ Safety Blackwoods, a leading industrial safety, engineering and workplace supplies provider, has successfully implemented Manhattan Associates' (NASDAQ: MANH) warehouse management solution, Manhattan SCALE, in two of its New Zealand based distribution centres (DCs). Since implementing Manhattan SCALE, NZ Safety Blackwoods has enhanced its warehouse processes including annual cycle count, which has seen a significant improvement in completion and anticipates completing its annual stock-take well ahead of schedule. Photo Credit: iStock With a 70 years heritage providing safety equipment, engineering, workwear, hygiene and packaging in New Zealand, NZ Safety Blackwoods, part of the Wesfarmers Industrial and Safety group, is known for its superior service, accuracy, and fulfillment speed across its national network of 34 trade centres. Operating four DCs across New Zealand and a dedicated warehouse for steel strapping supplies, the company faced pressure to meet growing user and trade centre demand, requiring enhancements to its supply chain and warehouse operations. The company chose to implement Manhattan SCALE, a robust warehouse management system (WMS) designed to streamline and optimise warehouse operations. Manhattan SCALE provides comprehensive tools to manage inventory, track shipments, and improve order accuracy, all while ensuring real-time visibility into operations to boost efficiency, reduce costs and improve customer satisfaction. "Manhattan SCALE has delivered significant improvements in real-time visibility, optimising picking routes, stock placement, bin capacities, and warehouse space utilisation," commented Chris Mason, New Zealand Safety Blackwoods, head of operations. "Pickers are no longer required to rely on personal knowledge of stock location to find goods. Since its deployment, we have reported a reduction in picking errors from an average of 3.5% to below 1% - a significant improvement for the high-volume operation." As New Zealand Safety Blackwoods prepares to consolidate its three Auckland-based DCs into a single, state-of-the-art distribution centre by 2026, Manhattan SCALE will be instrumental in preparing both its new automated infrastructure and the workforce for the transition, ensuring a smoother changeover and readiness for the enhanced workflows expected in the new facility. "The shift to a consolidated, automated DC will allow us to fulfill customer orders faster and more accurately, with orders potentially arriving in a single shipment instead of multiple deliveries from separate locations. With SCALE, we are building a foundation that will support our strategic growth and ensure that our operations remain agile and efficient," Mason added. "NZ Safety Blackwoods is a fantastic example of how leveraging advanced warehouse management technology can unlock new levels of operational efficiency and accuracy," said Raghav Sibal, Australia-New Zealand managing director of Manhattan Associates. "We're proud to support its journey as the team modernises operations and prepares for future growth through automation." ABOUT MANHATTAN ASSOCIATES Manhattan Associates is a global technology leader in supply chain and omnichannel commerce. We unite information across the enterprise, converging front-end sales with back-end supply chain execution. Our software, platform technology and unmatched experience help drive both top-line growth and bottom-line profitability for our customers. Manhattan Associates designs, builds, and delivers leading edge cloud and on-premises solutions so that across the store, through your network or from your fulfillment centre, you are ready to reap the rewards of the omnichannel marketplace. For more information, please visit www.manh.com ABOUT NZ SAFETY BLACKWOODS With over 70 years' experience in New Zealand, nobody has more in-depth knowledge of providing safety equipment, engineering, workwear, hygiene and packaging than NZ Safety Blackwoods. With 30 Trade Centres across New Zealand, a comprehensive digital platform, knowledgeable sales and service reps, an award-winning customer experience team, and a range of over 120,000 products – partnering with NZ Safety Blackwoods allows you to leverage our scale, knowledge and relationships with preferred suppliers to access the best products at the right price. With our vast product range, long history of servicing all sectors of New Zealand, and extensive portfolio of specialist and technical services, we will work with you to design and implement end-to-end specialist solutions in order to meet your purchasing requirements, providing you with everything you need from a trusted single source supplier. Employing over 500 team members across New Zealand, NZ Safety Blackwoods encourages diversity and a working environment in which employees are treated with equality, fairness and respect. https://nzsafetyblackwoods.co.nz/en/
-
CNOOC Limited Brings On-stream Bozhong 26-6 Oilfield Development Project (Phase I)
HONG KONG, Feb. 7, 2025 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) today announces that Bozhong 26-6 Oilfield Development Project (Phase I) has commenced production. The project is located in central Bohai Bay, with an average water depth of approximately 20 meters. The main production facilities include a new central processing platform and an unmanned wellhead platform. A total of 33 development wells are planned to be commissioned, including 22 production wells, 10 gas injection wells and 1 water source well. The project is expected to achieve a peak production of approximately 22,300 barrels of oil equivalent per day in 2025. The oil property is light crude. Bozhong 26-6 Oilfield is the world's largest metamorphic buried hill oilfield with cumulative proven oil and gas in-place of over 200 million cubic meters. Benefiting from the application of standardized engineering, it took only three years from the discovery of the oilfield to production, realizing the rapid conversion of reserves to production. As one of the demonstration CCUS projects of the Company in Bohai, it adopts advanced technology to capture and separate the associated carbon dioxide from crude oil extraction and reinject back into the formation to drive the oil, thereby increasing production while reducing emissions. The project is expected to bury approximately 1.5 million tons of carbon dioxide throughout its life cycle. Mr. Yan Hongtao, the President of CNOOC Limited, said, "The successful commencement of production of Bozhong 26-6 Oilfield Development Project (Phase I) marks a new stage for the Company in the development of offshore deep play complicated buried hill oil and gas reservoirs as well as the construction of the Bohai CCUS base. It bolsters the Company's energy supply capacity and low-carbon development in the Beijing-Tianjin-Hebei and Bohai Rim regions." CNOOC Limited holds 100% interest in this project and is the operator. — End — Notes to Editors: More information about the Company is available at http://www.cnoocltd.com. *** *** *** *** This press release includes forward looking information, including statements regarding the likely future developments in the business of the Company and its subsidiaries, such as expected future events, business prospects or financial results. The words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify such forward-looking statements. These statements are based on assumptions and analyses made by the Company as of this date in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors that the Company currently believes are appropriate under the circumstances. However, whether actual results and developments will meet the current expectations and predictions of the Company is uncertain. Actual results, performance and financial condition may differ materially from the Company's expectations, including but not limited to those associated with macro-political and economic factors, fluctuations in crude oil and natural gas prices, the highly competitive nature of the oil and natural gas industry, climate change and environmental policies, the Company's price forecast, mergers, acquisitions and divestments activities, HSSE and insurance policies and changes in anti-corruption, anti-fraud, anti-money laundering and corporate governance laws and regulations. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements. The Company cannot assure that the results or developments anticipated will be realised or, even if substantially realised, that they will have the expected effect on the Company, its business or operations. *** *** *** *** For further enquiries, please contact: Ms. Cui LiuMedia & Public RelationsCNOOC LimitedTel: +86-10-8452-6641Fax: +86-10-8452-1441E-mail: mr@cnooc.com.cn Mr. Bunny LeePorda Havas International Finance Communications GroupTel: +852 3150 6707Fax: +852 3150 6728E-mail: cnooc.hk@pordahavas.com
-
Aquaron Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination
NEW YORK, Feb. 7, 2025 /PRNewswire/ -- Aquaron Acquisition Corp. (NASDAQ: AQU, the "Company"), a special purpose acquisition company, announced today that HUTURE Ltd. ("Huture") has deposited into the Company's trust account (the "Trust Account") an aggregate of $20,000, in order to extend the period of time the Company has to complete a business combination for one additional month, from February 6, 2025 to March 6, 2025. The Company issued a promissory note to Huture with a principal amount equal to the amount deposited. The promissory note bears no interest and is convertible into the Company's shares of common stock at a price of $10.00 per unit (each unit is consisted of one share of common stock and one right to receive one-fifth (1/5) of a share of common stock) at the closing of a business combination by the Company. The purpose of the extension is to provide more time for the Company to complete a business combination. About Aquaron Acquisition Corp. Aquaron Acquisition Corp. is a Delaware corporation incorporated as a blank check company for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company's efforts to identify a prospective target business will not be limited to a particular industry or geographic region, although it intends to focus on operating businesses in the new energy sector. The Company affirmatively excludes as an initial business combination target any company of which financial statements are audited by an accounting firm that the United States Public Company Accounting Oversight Board is unable to inspect for two consecutive years beginning in 2021 and any target company with China operations consolidated through a VIE structure. Forward-Looking Statements This press release includes forward-looking statements that involve risks and uncertainties. Forward looking statements are statements that are not historical facts. Such forward-looking statements, including the successful consummation of the Company's initial public offering, are subject to risks and uncertainties, which could cause actual results to differ from the forward looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.
-
DoxAI to join UAE's Nextgen FDI Initiative to Drive AI-Powered Business Transformation
- DoxAI to establish regional headquarters in Dubai, leveraging AI-driven automation and insights to streamline business operations - Move supports the UAE's vision to become a global hub for advanced technology and innovation - HE Al Zeyoudi: "DoxAI will strengthen the UAE's innovation ecosystem and contribute to the digital transformation of industries, reinforcing our position as a global technology leader." ABU DHABI, UAE, Feb. 7, 2025 /PRNewswire/ -- The UAE Ministry of Economy has announced that DoxAI, a provider of AI solutions designed to simplify business processes and reduce operational complexities, has joined its NextGen FDI initiative. The program, which seeks to attract high-growth advanced technology companies to the UAE, will support DoxAI in establishing its regional headquarters in Dubai and scaling its operations to serve regional and global markets. DoxAI applies AI and machine learning to streamline document processing, automate data extraction, and enhance identity verification, delivering real-time, actionable insights for businesses. By reducing the need for human intervention and integrating seamlessly with existing business systems, DoxAI enables organisations to optimise their operations, reduce costs, and focus on strategic initiatives that drive growth. DoxAI is part of the Global Tech Builder Lakeba Group. His Excellency Dr Thani bin Ahmed Al Zeyoudi, UAE Minister of State for Foreign Trade, said, "We are delighted to welcome DoxAI to the NextGen FDI initiative. Their expertise in AI-driven automation will play a vital role in supporting the UAE's digital transformation journey and further strengthening our advanced technology ecosystem. This collaboration not only aligns with our vision to foster a knowledge-based economy but also reaffirms our commitment to positioning the UAE as a global hub for innovation and entrepreneurship." The company's regional headquarters will initially be based in Dubai's iconic Rolex Tower, with plans to deploy its first 15 units from Australia and India. DoxAI also aims to expand its presence in the UAE by forming strategic partnerships with local universities, such as the University of Wollongong, and developing a talent recruitment plan for the 2025-2026 period. Giuseppe Porcelli, Founder and Chairman of DoxAI, stated, "The UAE is a dynamic and forward-thinking market, offering unparalleled infrastructure, a business-friendly environment, and access to a vibrant technology ecosystem. Joining the NextGen FDI program is a game-changer for DoxAI. The UAE's visionary approach to AI and innovation provides the perfect environment for us to scale our technology, forge new partnerships, and contribute to the region's digital transformation." The UAE's focus on artificial intelligence aligns with its broader ambitions to enhance digital infrastructure, create smart industries, and attract cutting-edge technology companies. By fostering public-private partnerships and supporting businesses like DoxAI, the UAE is strengthening its leadership in emerging technologies that drive economic growth and diversification. Launched in 2022, the NextGen FDI initiative is designed to attract high-growth and highpotential advanced technology companies to the UAE. The initiative provides fast-tracked and simplified licensing, visa processes, accelerated access to banking services, and competitive rates for commercial and residential leases. It has already welcomed global innovators across sectors such as robotics, precision fermentation, hybrid aviation, and renewable energy.
-
Arcadium Lithium Announces Date for Fourth Quarter and Full Year 2024 Earnings Release
PHILADELPHIA and PERTH, Australia, Feb. 7, 2025 /PRNewswire/ -- Arcadium Lithium plc (NYSE: ALTM, ASX: LTM, "Arcadium Lithium") today announced it will release fourth quarter and full year 2024 earnings results on Thursday, February 27, 2025, after stock market close via PR Newswire and the company's investor relations website at: https://ir.arcadiumlithium.com. As a result of its pending acquisition by Rio Tinto, and as is customary during such transactions, Arcadium Lithium will not hold an earnings conference call in connection with its fourth quarter financial results. Arcadium Lithium Contacts Investors:Daniel Rosen +1 215 299 6208daniel.rosen@arcadiumlithium.com Phoebe Lee +61 413 557 780phoebe.lee@arcadiumlithium.com Media:Karen Vizental +54 9 114 414 4702karen.vizental@arcadiumlithium.com About Arcadium LithiumArcadium Lithium is a leading global lithium chemicals producer committed to safely and responsibly harnessing the power of lithium to improve people's lives and accelerate the transition to a clean energy future. We collaborate with our customers to drive innovation and power a more sustainable world in which lithium enables exciting possibilities for renewable energy, electric transportation and modern life. Arcadium Lithium is vertically integrated, with industry-leading capabilities across lithium extraction processes, including hard-rock mining, conventional brine extraction and direct lithium extraction (DLE), and in lithium chemicals manufacturing for high performance applications. We have operations around the world, with facilities and projects in Argentina, Australia, Canada, China, Japan, the United Kingdom and the United States. For more information, please visit us at www.ArcadiumLithium.com. Important Information and Legal Disclaimer:Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain statements in this news release are forward-looking statements. In some cases, we have identified forward-looking statements by such words or phrases as "will likely result," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "predicts," "forecasts," "estimates," "projects," "potential," "intends" or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words and phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for Arcadium Lithium based on currently available information. There are important factors that could cause Arcadium Lithium's actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including the supply and demand in the market for our products as well as pricing for lithium and high-performance lithium compounds; our ability to realize the anticipated benefits of the integration of the businesses of Livent and Allkem or of any future acquisitions; our ability to acquire or develop additional reserves that are economically viable; the existence, availability and profitability of mineral resources and mineral and ore reserves; the success of our production expansion efforts, research and development efforts and the development of our facilities; our ability to retain existing customers; the competition that we face in our business; the development and adoption of new battery technologies; additional funding or capital that may be required for our operations and expansion plans; political, financial and operational risks that our lithium extraction and production operations, particularly in Argentina, expose us to; physical and other risks that our operations and suppliers are subject to; our ability to satisfy customer qualification processes or customer or government quality standards; global economic conditions, including inflation, fluctuations in the price of energy and certain raw materials; the ability of our joint ventures, affiliated entities and contract manufacturers to operate according to their business plans and to fulfill their obligations; severe weather events and the effects of climate change; extensive and dynamic environmental and other laws and regulations; our ability to obtain and comply with required licenses, permits and other approvals; and other factors described under the caption entitled "Risk Factors" in Arcadium Lithium's 2023 Form 10-K filed with the Securities and Exchange Commission ("SEC") on February 29, 2024, as well as Arcadium Lithium's other SEC filings and public communications. Although Arcadium Lithium believes the expectations reflected in the forward-looking statements are reasonable, Arcadium Lithium cannot guarantee future results, level of activity, performance or achievements. Moreover, neither Arcadium Lithium nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. Arcadium Lithium is under no duty to update any of these forward-looking statements after the date of this news release to conform its prior statements to actual results or revised expectations. Logo - https://mma.prnasia.com/media2/2310012/Arcadium_Lithium_Horizontal_Logo.jpg?p=medium600
-
AMPA, E-Mobility, and Autotronics 2025: Creating a Comprehensive Smart Mobility Exhibition Platform
TAIPEI, Feb. 7, 2025 /PRNewswire/ -- The Taiwan External Trade Development Council (TAITRA) will present Taipei AMPA and E-Mobility Taiwan under the new "360° MOBILITY Mega Shows" brand at Nangang Exhibition Hall 1 from April 23-26, 2025. Running concurrently with these shows will be the Autotronics Taipei, collectively establishing Asia's most comprehensive mobility industry exhibition platform. As benchmark exhibitions for the global automotive parts industry, these three shows will feature 13 newly integrated exhibition zones. The comprehensive display ranges from hardware components, aftermarket services, and automotive electronics to software/hardware and system solutions, as well as electric vehicles, autonomous vehicles, and charging systems, presenting the most complete mobility industry ecosystem. In 2024, these flagship shows attracted over 50,000 professional visits and media representatives from 120 countries. The 2025 edition, themed "Drive Smart, Drive Sustainability," will focus on three key areas: Diverse Innovation, Sustainable Future, and Mobility Ecosystem. The exhibition will feature 13 specialized zones covering parts & components, customizing & accessories, automotive lighting, mobility technology, autonomous and electric vehicles, and motorcycle components, showcasing the latest technologies and future trends. With the global automotive industry's shift toward electrification and smart technology, the newly established Mobility Technology and Mobility Energy Solutions areas will feature industry leaders, such as CUB ELECPARTS, DELTA ELECTRONICS, ETREEGO, HD RENEWABLE ENERGY, SHIHLIN ELECTRIC, TEXAS INSTRUMENTS, and ZEROVA TECHNOLOGIES. These companies will showcase cutting-edge mobility solutions and innovative technologies. In the automotive components sector, leading manufacturers AISIN ELITE, GORDON, KUO CHUAN PRECISION, NAN HOANG, and SONAR AUTO PARTS will demonstrate their technological expertise, while EAGLE EYES and JUST AUTO LIGHTING will lead the automotive lighting segment with innovative lighting solutions. Industry forecasts project Taiwan's automotive electronics production value to exceed NT$600 billion in 2025, with electronic components expected to make up over 50% of total vehicle costs. The automotive electronics zone will showcase leading manufacturers including E-LEAD ELECTRONIC, JET OPTOELECTRONICS, KAI SUH SUH, MiTAC, MSI, and TA YA ELECTRIC WIRE & CABLE, highlighting Taiwan's competitiveness in the global market. To foster industry exchange and innovation, TAITRA will host key events, including the "360° MOBILITY Forum", where industry experts share insights on global market trends and technological developments. Additionally, the fourth annual "ESG Achievement", in partnership with international certification authorities, will recognize companies demonstrating excellence in sustainable development, encouraging broader industry adoption of sustainability practices. The 360° MOBILITY Mega Shows demonstrate Taiwan's innovative capabilities in the mobility sector while providing an excellent platform for industry professionals to collect, explore global trends, and foster business opportunities. International visitors can obtain badges by presenting the QR code from their pre-registration confirmation email along with two business cards. For more information and pre-registration: https://www.taipeiampa.com.tw/en/.
-
COLE HAAN CELEBRATES SPRING WITH INNOVATION THAT MOVES YOU
The Iconic American Brand Introduces a New Era of Footwear and Accessories Combining Cutting-Edge Ergonomics with Effortless Style NEW YORK, Feb. 6, 2025 /PRNewswire/ -- This spring, Cole Haan channels the renewed energy of the season with its latest global campaign, Innovation That Moves You—a celebration of visionary design crafted for the rhythm of real life. At Cole Haan, innovation goes beyond integrated functionality; it's about technology and meticulous craft that effortlessly adapts to your day to evening, wherever it takes you. From your commute to a client meeting to a last-minute dinner, it's innovation that empowers you to move through life with comfort, confidence, and effortless style. Experience the full interactive Multichannel News Release here: https://www.multivu.com/cole-haan/9313651-en-cole-haan-innovation-that-moves-you-spring-campaign As one of America's most enduring footwear and accessories brands, Cole Haan has been synonymous with craftsmanship, design, and versatility since 1928. For nearly a century, the brand has revolutionized the industry with innovations that honor its rich heritage while evolving to meet the ever-changing needs of its customers—empowering them in their every pursuit. "Style backed by state-of-the-art comfort is always a priority at Cole Haan," says Scott Patt, Chief Creative Officer of Cole Haan. "For Spring 2025, we've created elevated, beautiful products with a fresh sense of energy, rooted in Cole Haan DNA—designed for those who value versatility and modern elegance. The Spring 2025 campaign and collection features smart, stylish footwear, accessories, and outerwear that effortlessly support today's dynamic lifestyles. We look forward to seeing how our customers connect with these designs, where quality, craftsmanship, and innovation intersect." Innovation That Moves You is the fifth creative collaboration brought to life with General Idea, a next-generation and award-winning creative agency. The campaign will run across digital and social platforms, connected TV, as well as out of home in the U.S. and select international markets. In the Women's collection, Cole Haan introduces the Georgie Ballet Flat, designed to effortlessly transition from office to off-duty looks. Also debuting is the Graclyn Mary Jane Ballet Flat, featuring a classic buckle strap detail and a back pull tab for easy wear. Both styles are crafted with a rounded toe and a soft, glove-like upper, offering a blend of style and functionality. Designed with ultra-flexible outsoles to be bendable, foldable, and packable, these go-anywhere flats are engineered to mimic the foot's natural motion, reducing fatigue while delivering unmatched comfort and elegance. The Georgie Ballet Flat retails for $140, and the Graclyn Mary Jane Ballet Flat retails for $150. Cole Haan's Women's Spring 2025 collection also introduces: The "take you where you need to go sneaker," the GrandPrø Eleeana Runner, lends ease to each step with precision engineering, whether you're running errands or on your morning route. Later in the season, the GrandPrø Harbor Sneaker, inspired by archive pieces and distinguished by a meticulous, textured weave of suede and canvas, is a balance of refined and casual—perfect for everyday and all-day comfort. The Marisol Footbed Sandal offers a perfect blend of cushion and support for warm-weather adventures. Complete with adjustable straps, a molded footbed, and a sumptuous leather upper, this lightweight slide is a reimagined take on a season-spanning classic. In handbags, the Carolyn Foldover Tote is the ultimate multi-functional must-have. Designed with a braided top handle, a removable and adjustable crossbody leather strap and a chain strap, this versatile bag seamlessly transforms from a tote to a crossbody to a clutch—making it the perfect go-to, go-anywhere handbag for spring. Leading the Men's collection is Cole Haan's latest: ØriginalGrand™ Energyweave Oxfords. Featuring a proprietary FlowerFlex™ sole with multi-directional flexibility and traction, the ØriginalGrand™ Energyweave Oxford is re-engineered with Cole Haan's new Energy Rebound Cushioning Compound to absorb shock and help propel you forward. Also included is Cole Haan's patented FlowerFoam™ cushioning system, made with a minimum of 25% dandelion rubber for sustainable comfort. The Energyweave Oxfords are available in Perforated Plain-toe and Wingtip styles as well as a variety of different colors and retailing for $170. Cole Haan's Men's Spring 2025 collection also introduces: Refined lifestyle sneakers, like the GrandPrø Luxe Wholecut Sneaker distinguished by premium wholecut leather upper and crafted dress details, featuring a durable, luxuriously cushioned FlowerFoam™ inner sole with a rubber outsole for all-day comfort and ease. Additionally, the new GrandPrø Millenia Sneaker combines the nostalgia of a 2000s performance runner with a modern twist. Lastly, the GrandPrø Luxe Slip-On is the easy on/off sneaker perfect the office or out-of-office travel. New Dual Gender performance styles, including the ØriginalGrand™ Quadstar Monk Strap Running Sneakers and ØriginalGrand™ Quadstar Running Sneakers are ultra-lightweight with exceptional rebound for a responsive, comfortable run. The Innovation That Moves You global campaign, along with Cole Haan's latest product offerings, is now live at www.ColeHaan.com and available in U.S. and select international retail stores worldwide. To find a Cole Haan store location, customers can find the extensive list of international distributors and websites on ColeHaan.com. ABOUT COLE HAAN Cole Haan is a global American lifestyle brand distributed in over 100 countries across the world serving always-connected, active professionals with innovative footwear and lifestyle accessories. With a nearly 100-year heritage, Cole Haan infuses its products with time-honored craftsmanship and modern innovation, making footwear and lifestyle accessories that customers wear from work, to workout, to weekend. Cole Haan's mission is to inspire customers to live extraordinary lives. PRESS CONTACT The Lede Company colehaan@ledecompany.com
-
Goeroptics Debuts Innovative AR Etching Waveguide and DLP 3D Printing Light Engine Module
SAN FRANCISCO, Feb. 6, 2025 /PRNewswire/ -- Goertek Optics Technology Co. ("Goeroptics"), a subsidiary of Goertek, has unveiled its latest full-color augmented reality (AR) etching waveguide module, Star G-E1, and its proprietary DLP (Digital Light Processing) 3D printing light engine at the SPIE (International Society for Optics and Photonics) AR | VR | MR 2025 and TCT Japan, highlighting the company's continuous advancements and expansions in the optics sector. The Star G-E1 module, featuring high-refractive-index materials and etching surface relief grating technology, delivers unparalleled display performance. It boasts high uniformity, high brightness, and low stray light, ensuring crystal-clear visuals even in bright environments. This innovation overcomes the limitations of traditional nanoimprint techniques in high-refractive-index material applications, offering a wider range of refractive index options and enhanced UV resistance. By optimizing the grating material and structure, the Star G-E1 achieves a peak brightness of 5,000 nits, with brightness uniformity exceeding 45% and color difference less than 0.02. The improvements represent a 50% and 100% enhancement, respectively, over similar technical solutions. This significantly reduces image color deviation and elevates color performance, resulting in vibrant, clear, and impurity-free images. Furthermore, the Star G-E1 features a sleek, single-layer optical waveguide that is just 0.7 millimeters thick. It incorporates an industry-leading micro-LED display solution, with the light engine volume under 0.5 cubic centimeters. The compact design delivers exceptional optical display performance, paving the way for lightweight AR glasses that provide a delicate, realistic, and natural viewing experience. With the continued evolution of the 3D printing industry and the increasing demand for high-precision printing, optical modules in 3D printing equipment are facing more stringent performance requirements. Precise light field control is critical for 3D printing light engines to reduce errors and improve the quality and consistency of printed products. At TCT Japan, Goeroptics introduced a state-of-the-art DLP-based 3D printing light engine that raises the bar. Supporting high resolutions of 4K and 1080P, the module significantly improves printing accuracy. The 3W high output power shortens the curing time for each layer of material, accelerating printing speed. The contrast ratio exceeds 1000:1, effectively minimizing print residue. In addition, the light engine boasts 90% uniformity, ensuring that printed product details are sharp and features are intact. Distortion control is maintained within 0.1%, ensuring the shape and size of printed products are accurate. The light engine also features an all-glass lens and all-metal structural design, coupled with robust thermal management, ensuring stability and durability during prolonged operation, and extending the life of the device. In addition to its 3D printing offerings, Goeroptics showcased its innovative 3D scanning light engines and laser modules for precise 3D profiler measurements. The 3D scanning light engine leverages DLP technology to rapidly display various high-resolution structured light patterns, capturing intricate surface details and enhancing 3D model accuracy for a wide range of applications. The laser module, utilizing line laser technology, precisely scans object surfaces to measure their 3D contours. With a Gaussian degree of over 90%, uniform scanning lines, and high accuracy, it is perfectly suited for inspection tasks in the 3C electronics, lithium battery, and PCB segments. Since 2017, Goeroptics has been developing DLP projection light engines, providing end-to-end solutions from optical design to assembly. The company continues to expand its research and manufacturing capabilities in micro-nano optical components and laser modules. Looking ahead, Goeroptics remains committed to pushing the boundaries of precision optics, offering high-performance, cost-effective solutions to clients worldwide.
-
Personetics' New Features Give Banks More Ways to Monetize Customer Wellness
Personetics' latest product release empowers financial institutions to develop highly personalized customer experiences that democratize financial advice, inspire action, and drive business value NEW YORK, Feb. 6, 2025 /PRNewswire/ -- Personetics, the company transforming how banks build and monetize customer relationships, announced a series of new features for its AI-powered flagship product, Personetics Engage. These enhancements enable financial institutions to create personalized digital experiences that empower customers to become smarter about their money and more motivated to take action. They also reflect Personetics' deep understanding of how banks can better serve their customers by dynamically responding to their evolving financial needs. Personetics’ New Features Give Banks More Ways to Monetize Customer Wellness The release introduces capabilities that expand banks' ability to create, control, and customize digital banking experiences that redefine how banks interact with their customers. Key features include: Activity Tracker that offers customers an interactive overview of their spending, income, and cash flow for up to 12 months. This enhanced visibility helps customers easily track and manage their financial activity across accounts from a single place. Financial Recap helps customers stay on top of their finances at a glance with an Instagram-like summary of their spending over the past seven days. It features top merchants and categories and provides a seven-day outlook of their forecasted balance and projected activities. Rather than just listing transactions, this feature contextualizes information by emphasizing important spending trends and potential areas of concern, including personalized calls to action that banks can customize. Bank and User Categorization Control enables banks to influence transaction categorization mapping for improved accuracy. Banks can review, recategorize, rename, and even create their own unique categories to align with their evolving business and local needs. In addition, end-customer recategorization and editing options provide an additional feedback loop that ensures a more personalized and accurate display of their transactions, recurring activities, and forecasted balance. Custom User Journeys introduce a new level of interactive engagement between banks and their customers. Banks can now create targeted, dynamic flows that gather customer preferences and adapt in real time. These flows deliver personalized financial guidance and product recommendations based on direct customer input, with customizable and interactive insights, questionnaires, and teasers. The Personetics approach enables financial institutions to independently create and modify insights through an intuitive management console—a feature that competitive solutions often lack without substantial vendor involvement. "Financial institutions today need solutions that go beyond basic personalization and static insights," said Ron Agam, Chief Product Officer at Personetics. "These new capabilities advance our mission of providing banks with a platform that dynamically responds to their customers' changing financial needs, making them smarter about their money and motivated to act." These latest innovations reinforce Personetics' commitment to shaping the future of digital banking—one where financial institutions don't just serve customers but actively empower them. Using AI, Personetics transforms how banks build and monetize customer relationships, turning everyday banking into a more personalized, data-driven experience. By doing so, banks foster deeper engagement, drive meaningful action, and ultimately enhance their customers' financial well-being. About Personetics Personetics is the global leader in transforming how banks build and monetize customer relationships by enabling them to dynamically respond to consumers' evolving financial needs with contextual and highly relevant insights, making them smarter about their money and eager to act. The AI-powered SaaS platform allows financial institutions to boost customer engagement and satisfaction, resulting in increased digital adoption and sales conversions. Personetics supports 150 million customers across 35 global markets and serves leading financial institutions. The company has offices in New York, London, Singapore, São Paulo, and Tel Aviv. For more information, visit https://personetics.com. Media contact: Ellery Smithpersonetics@fullyvested.com
-
Stroke Detection Innovator Wellumio Enrolls First Patient in Australian Clinical Trial for 'Axana' 0.1T portable magnetic resonance imaging
"Revolutionary portable device leverages advanced magnetic resonance technology to rapidly detect acute stroke biomarkers, enabling frontline care teams to make faster, life-saving decisions within the critical 'golden hour." A Melbourne hospital images the first patient in Australia using the Wellumio Axana device, marking a milestone in advancing rapid acute stroke detection in the Emergency Room. With a unique ability to perform rapid MRI-based stroke imaging at the patient's bedside, Wellumio takes a major step toward generating the clinical evidence required for adoption of the Axana device. MELBOURNE, Australia, Feb. 7, 2025 /PRNewswire/ -- Wellumio, a New Zealand-based medical device company pioneering advancements in stroke detection, today announced enrollment of the first patient in the Feasibility, safety, and usability assessment of the Wellumio 'Axana' 0.1T portable magnetic resonance imaging device (Portable MRI study) which will study the ability of the Axana device to detect acute stroke in ED patients. The Axana device, through its compact, portable design, enables the user to rapidly track the magnetic resonance properties of brain tissue and identify clinically proven stroke biomarkers, such as molecular diffusion identified by Diffusion Weighted Imaging (DWI) at the patient's bedside. The Melbourne hospital recently assessed the first case using the Wellumio Axana device. The care team there performed the scan on a 77-year-old female suspected of acute stroke with the Wellumio Axana device. The Portable MRI study is a two-part, dual-center, feasibility/ observational study of the Wellumio 'Axana' 0.1T brain scanning device in subacute stroke patients. The primary objective of this first clinical study is to assess the safety (adverse events) and feasibility (ability to acquire a scan in a timely manner without technical fault) of the Wellumio 'Axana' device in the hospital setting with healthy controls and stroke patients. Secondary objectives include 1) assessing usability of the Axana device, 2) acquiring physiological data from healthy controls and hospital patients with the Axana device to investigate the agreement with hospital MRI, and 3) investigating the repeatedly and reproducibility of scans acquired with the Axana device within and between participants. The clinical study is supported by the Australian Stroke Alliance, principal study partner, and managed by Titan Prehospital Innovation, a Clinical Research Organisation in partnership with the Australian Stroke Alliance. "This innovative imaging approach to stroke detection has the potential to accelerate treatment and improve patient outcomes. MRI techniques have the potential to sensitively diagnose stroke," said Professor Stephen Davis, co-principal investigator. "Integrating this type of technology in the pre-existing workflow by bringing MRI imaging to the patient has the potential, if successful, to improve acute stroke assessment and treatment. That makes this an exciting innovation milestone as we enroll the first patient in this important first clinical trial," added Professor Geoffrey Donnan, co-principal investigator. "We've designed a novel device that is highly portable and significantly faster than traditional MRIs, making it ideal for quick assessments in emergency situations," said Dr. Shieak Tzeng, CEO of Wellumio. "By delivering radial maps of the brain, Axana will potentially empower emergency physicians, neurologists, radiologists, and stroke care team members to rapidly detect strokes and guide critical treatment decisions during the crucial golden hour of care." Unlike conventional MRIs, which rely on superconducting magnets and large coils to generate magnetic gradients for imaging, Axana's innovative technology is powered by Pulsed Gradient Free Mapping (PGFM). This groundbreaking approach eliminates the need for bulky components, enabling the device to track the magnetic resonance properties of brain tissue and identify clinically proven stroke biomarkers, such as molecular diffusion, in a compact, portable design. Axana's portability and simplicity make it ideal for bedside use, where it enables fast detection of stroke-related damage and provides critical insights into its severity and extent. By delivering this information quickly, Axana supports the prioritization of advanced imaging and guides urgent treatment decisions. About WellumioWellumio is a New Zealand-based medical device company transforming acute stroke care with its innovative Axana® device. The portable, lightweight technology utilizes a groundbreaking Pulsed Gradient Free Mapping (PGFM) method to rapidly identify areas of brain tissue affected by stroke. Designed to address the limitations of traditional MRI systems, Axana enables frontline healthcare workers in diverse settings, including emergency departments and ICUs, to make timely, life-saving interventions within the critical golden hour, leading to better patient outcomes. To learn more, visit www.wellumio.com Logo - https://mma.prnasia.com/media2/2590360/Copy_of_99d_wellumio_logo_RGB_wellumio_main_Logo.jpg?p=medium600
-
WeRide Launches Robovan W5, Pioneering New Class of Autonomous Delivery Vehicle
GUANGZHOU, China, Feb. 6, 2025 /PRNewswire/ -- WeRide Inc. (NASDAQ: WRD), a global leader in autonomous driving technology, today launched the Robovan W5, featuring self-developed Level 4 autonomous technology that operates 24/7 in all weather conditions. It offers long-distance and bulk delivery capabilities integrating vehicle, cloud, and operations to address key challenges in the logistics industry, particularly in express delivery, urban distribution and various point-to-point logistics, with a cost-effective unmanned delivery solution. WeRide (NASDAQ: WRD) launches the Robovan W5, featuring self-developed Level 4 autonomous technology that operates 24/7 in all weather conditions. As a Level 4 autonomous logistics vehicle designed for urban open roads, Robovan W5 is built on WeRide's almost 1,900 days of autonomous operations, and nearly 40 million kilometers of autonomous driving mileage on public roads. It features WeRide's self-designed redundant sensor kit, which detects vehicles, traffic lights, pedestrians, and other road users, while providing 360-degree blind-spot-free perception to operate 24/7 in various traffic conditions. The WeRide Robovan W5 is tailored for high-frequency urban logistics. Features include the largest cargo capacity in its class at 5.5 cubic meters with 1,000 kg maximum payload, and operating range of up to 220 kilometers. The Robovan W5 navigates complex urban traffic environments with an intelligent path optimization system that analyzes traffic conditions in real-time, dynamically adjusting routes to avoid congestion. It allows modular cargo box stacking for different scenarios. The Robovan W5 supports multi-vehicle platooning, allowing single-operator management of multiple vehicles for standardized, scalable delivery. Its electric drive and 24/7 operations further reduce operation costs. Safety features include redundant drive-by-wire chassis, redundant perception, emergency braking, collision warning, driving status monitoring and intelligent Cloud Control Platform. Service features include cloud-based intelligent scheduling, real-time monitoring, task optimization, and data analytics, rapid deployment, and remote OTA upgrades. WeRide also provides 24/7 customer support, on-site training, customized solutions, comprehensive warranty, complimentary maintenance, vehicle replacement for quality issues, and IoT. "The Robovan W5 demonstrates WeRide's latest breakthrough in autonomous delivery and ability to adapt WeRide's proven autonomous driving technology across different urban scenarios with our self-developed universal autonomous driving technology platform WeRide One," said Dr. Tony Han, Founder and CEO of WeRide. "From our GXR Robotaxi serving passengers and Robosweeper cleaning the urban environment to the Robovan W5 handling urban logistics, we're creating a comprehensive ecosystem of autonomous driving solutions to cover diverse urban transportation needs."
-
Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.
SHANGHAI, Feb. 6, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) today announced it has entered into a license agreement with Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd., (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY, along with its subsidiaries hereafter referred to as "Dr. Reddy's") for the company's independently developed investigational daratumumab biosimilar HLX15, a recombinant anti-CD38 fully human monoclonal antibody injection. Dr. Reddy's will gain exclusive rights to commercialize both subcutaneous and intravenous formulation of HLX15 in a total of 43 countries and regions, comprising 42 European countries and regions and the United States (U.S.). Under the terms of the agreement, Henlius will be responsible for development, manufacturing and commercial supply, and may receive up to a total of $131.6 million, including a $33 million upfront payment and additional milestone payments. In addition, Henlius is eligible to receive royalties on annual net sales of the product. Dr. Reddy's is a global pharmaceutical company, operating in over 75 countries across the globe. Through a partnership with Dr. Reddy's, Henlius aims to boost the growth and reach of its products in the European and U.S. markets, providing local patients with enhanced treatment options. "This collaboration with Dr. Reddy's on HLX15 is a significant step in our response to global health needs and improving access to advanced biologics," said Dr. Jason Zhu, Executive Director and Chief Executive Officer of Henlius. "Dr. Reddy's has a long-standing dedication to oncology, driven by the purpose that 'Good Health Can't Wait', and is committed to timely access to affordable and high-quality medicines, which complement Henlius' focus on addressing unmet medical needs in research and development. We are confident that this partnership will enhance the global market competitiveness of both organizations in oncology treatment, ultimately allowing us to reach and support more patients around the world." "We are pleased to join hands with Dr. Reddy's, signifying a pivotal moment in Henlius' journey to expand our global partner network," said Ping Cao, Chief Business Development Officer and SVP of Henlius, "Henlius' robust product development capabilities in biosimilars, along with its advanced manufacturing and quality systems that meet global standards, paired with Dr. Reddy's vast experience and resources in the global commercialization of biosimilars, positions this collaboration to effectively harness the strengths of both organizations. Together, we aim to deliver more high-quality and affordable treatment options to the U.S. and European markets." Erez Israeli, Chief Executive Officer of Dr. Reddy's, said: "We are pleased to collaborate with Henlius to make this daratumumab biosimilar available to patients in the U.S., and Europe. Over the years, we have created a portfolio of biosimilar products that are being marketed in several emerging markets. This latest collaboration with Henlius further progresses our regulated markets journey in biosimilars. Additionally, oncology has been a top focus therapy area for us. We look forward to leveraging our strong commercial capabilities in these markets to ensure patients receive access to best-in-class therapies and affordable treatment options." About HLX15 HLX15 is a fully human anti-CD38 IgG1κ monoclonal antibody independently developed by Henlius, and is a biosimilar candidate to Darzalex® & Darzalex Faspro®* which are indicated for the treatment of multiple myeloma. In accordance with the biosimilar guidelines of NMPA, EMA, and USFDA, HLX15 is being developed following the principles of stepwise development. HLX15 and reference daratumumab are considered comparable based on analytical similarity assessment and pre-clinical studies. In June 2024, the Phase 1 clinical study (NCT05679258) of HLX15 was successfully completed, meeting its primary endpoint. The findings indicate that HLX15 had similar pharmacokinetic characteristics, as well as comparable safety and immunogenicity profiles to the US-, EU-, and CN-sourced daratumumab. Comparative efficacy studies are currently underway. *Darzalex® & Darzalex Faspro® are registered trademarks of Johnson & Johnson. About Dr. Reddy's Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines. Driven by our purpose of 'Good Health Can't Wait', we offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Our major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in businesses of the future. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. About Henlius Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases and ophthalmic diseases. Up to date, 6 products have been launched in China, 4 have been approved for marketing in overseas markets, and 4 marketing applications have been accepted for review in China, the U.S. and the EU, respectively. Since its inception in 2010, Henlius has built an integrated biopharmaceutical platform with core capabilities of high-efficiency and innovation embedded throughout the whole product life cycle including R&D, manufacturing and commercialization. It has established global innovation centre and Shanghai-based commercial manufacturing facilities certificated by China, the EU and U.S. GMP. Henlius has pro-actively built a diversified and high-quality product pipeline covering over 50 molecules and has continued to explore immuno-oncology combination therapies with proprietary HANSIZHUANG (anti-PD-1 mAb) as the backbone. To date, the company's launched products include HANLIKANG (rituximab), the first China-developed biosimilar, HANQUYOU (trastuzumab, trade name: HERCESSI™ in the U.S., Zercepac® in Europe), a China-developed mAb biosimilar approved in China, Europe and U.S., HANDAYUAN (adalimumab), HANBEITAI (bevacizumab), HANSIZHUANG (serplulimab, trade name: Hetronifly® in the EU), the world's first anti-PD-1 mAb for the first-line treatment of SCLC, and HANNAIJIA (neratinib). What's more, Henlius has conducted over 30 clinical studies for 16 products, expanding its presence in major markets as well as emerging markets.
-
Hexagon Purus upgrades to IFS Cloud to drive supply chain efficiency and optimize global growth
Leader in zero emissions mobility and infrastructure technology will deploy IFS.ai capabilities to meet global demand for market-leading hydrogen and battery electric technologies. LONDON, Feb. 6, 2025 /PRNewswire/ -- IFS, the leading enterprise cloud and Industrial AI software provider, today announced that Hexagon Purus, the global leader in zero emission infrastructure and mobility solutions, is set to implement IFS Cloud to increase efficiency across its entire supply chain – from material and capacity planning to financial management. Hexagon Purus has opened seven new manufacturing facilities across three continents within 18 months, to meet worldwide demand for its advanced hydrogen storage and battery systems technology and vehicle integration solutions. With IFS Cloud's advanced functionality, user-friendly simplicity, and superior third-party tool integration, the ERP solution will provide Hexagon Purus with critical Industrial AI-driven data insights for faster and better supply chain decisions. Headquartered in Norway, Hexagon Purus drives decarbonization across industry and mobility end-markets including light, medium, and heavy-duty trucking, buses, maritime, rail, aviation and aerospace and provides hydrogen ground storage, distribution and refueling. By implementing IFS Cloud, the company will gain greater transparency across every aspect of its supply chain and a detailed view of each customer order, driving significant improvements in operational performance. IFS Cloud's customizable dashboards will also provide Hexagon Purus employees with faster access to the data they need for their specific roles. The composable nature of the IFS Cloud platform enables Hexagon Purus to remain evergreen – no major upgrades required – on the latest innovation and functionality, reducing cost, increasing profitability and competitiveness. In the longer term, deployment of IFS Cloud will help the company achieve its digital transformation ambitions. Hexagon Purus will connect IFS Cloud to its own data integration platform to facilitate strategic supply chain decisions across all its sites, react even faster to changes in production output, quality and capacity, and provide a better customer experience through increased visibility. Heiko Chudzick, responsible for operations at Hexagon Purus, said: "Our technology and manufacturing expertise is second-to-none and so it was natural that we would move to IFS Cloud as we expand to meet the growing demand for our zero emission mobility solutions. Upgrading to IFS Cloud and utilizing its advanced AI capabilities will help us become even more efficient and competitive. This transition is a critical part of our overall digitalization journey and we're excited to continue working with IFS as we enhance our global supply chain operations to drive a more sustainable planet." Clemens Mittnacht, Senior Director, Market Unit Leader DACH, IFS, said: "Hexagon Purus' decision to upgrade to IFS Cloud will transform the efficiency, competitiveness and agility of its fast-expanding global supply chain. As a global leader in the use of advanced technology to reduce and eliminate harmful emissions from mobility, their expertise is unparalleled. With a shared commitment to innovation, we are proud to collaborate and help Hexagon Purus achieve its digital transformation ambitions, leverage Industrial AI and increase sustainability worldwide." About Hexagon Purus Hexagon Purus enables zero emission mobility for a cleaner energy future. The company is a world leading provider of hydrogen Type 4 high-pressure cylinders and systems, battery systems and vehicle integration solutions for fuel cell electric and battery electric vehicles. Hexagon Purus' products are used in a variety of applications including light, medium and heavy-duty vehicles, buses, ground storage, distribution, refueling, maritime, rail and aerospace. Learn more at www.hexagonpurus.com and follow @HexagonPurus on X and LinkedIn IFS Press Contacts:EUROPE / MEA / APJ: Adam GillbeIFS, Director of Corporate & Executive CommunicationsEmail: adam.gillbe@ifs.com NORTH AMERICA / LATAM: Mairi MorganIFS, Director of Corporate & Executive CommunicationsEmail: mairi.morgan@ifs.com This information was brought to you by Cision http://news.cision.com. https://news.cision.com/ifs/r/hexagon-purus-upgrades-to-ifs-cloud-to-drive-supply-chain-efficiency-and-optimize-global-growth,c4101766 The following files are available for download: https://news.cision.com/ifs/i/hexagonpurus1-930x423,c3375018 HexagonPurus1 930x423
-
Yum China Reports Fourth Quarter Results and Increases Dividend by 50%
Fourth Quarter Operating Profit Grew 36% and OP Margin1 Expanded 140 Basis PointsSequential Improvement in Same-Store Sales Index and Eighth Consecutive Quarter of Same-Store Transaction GrowthFull Year Operating Profit Rose 5% to $1.2 Billion, Core Operating Profit2 Up 12% and Diluted EPS Up 18%Record 2024 Results: Total Revenues of $11 Billion, 1,751 Net New Stores and $1.5 Billion Capital Returned to Shareholders SHANGHAI, Feb. 6, 2025 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE: YUMC and HKEX: 9987) today reported unaudited results for the fourth quarter and year ended December 31, 2024. Fourth Quarter Highlights Total system sales grew 4% year over year ("YoY"), excluding foreign currency translation ("F/X"). The growth was primarily attributable to 5% of net new unit contribution.3 Same-store sales reached 99% of the prior year's level and improved sequentially from 97% in the third quarter. Same-store transactions grew 4% YoY, the eighth consecutive quarter of growth. Total revenues increased 4% YoY to $2.6 billion, a record-high for the fourth quarter (a 4% increase excluding F/X). The Company opened 534 net new stores and reached 16,395 stores as of December 31, 2024. Operating profit grew 36% YoY to $151 million. Core operating profit grew 35% YoY. OP margin was 5.8%, an increase of 140 basis points YoY, supported by restaurant margin expansion. Restaurant margin was 12.3%, an increase of 160 basis points YoY. Excluding $6 million in items affecting comparability, restaurant margin increased 180 basis points YoY, driven primarily by improved operational efficiencies. Diluted EPS increased 30% YoY to $0.30, or up 27% YoY excluding F/X. Excluding the impact of $0.01 from F/X and the mark-to-market equity investments in the fourth quarters of 2024 and 2023, Diluted EPS increased 20% YoY. Full Year Highlights Total system sales grew 5% year over year, excluding F/X. The growth was primarily attributable to 7% of net new unit contribution. Same-store sales reached 97% of the prior year's level for the year. Total revenues increased 3% YoY to $11.3 billion, a record level since the spin-off. Excluding F/X, total revenues would have been $200 million higher, or a 5% increase YoY. Store count increased 12%, or 1,751 net new stores, with 512 net new stores, or 29% opened by franchisees. Delivery sales grew 14% YoY, maintaining the double-digit annual growth Yum China has sustained over the past decade. Delivery contributed approximately 39% of KFC and Pizza Hut's Company sales. Operating profit grew 5% YoY to $1.2 billion. Core operating profit grew 12% YoY. OP margin was 10.3%, up 20 basis points YoY, supported by resilient restaurant margins and savings in G&A expenses. Restaurant margin was 15.7%. Excluding $60 million in items affecting comparability, restaurant margin was flat YoY. Diluted EPS increased 18% YoY to $2.33, a record-high for the year, or up 22% YoY excluding F/X. Excluding the impact of $0.11 from F/X and the mark-to-market equity investments, Diluted EPS increased 12% YoY. Returned $1.5 billion to shareholders in 2024 through $248 million in cash dividends and $1.24 billion in share repurchases, representing approximately 8% of outstanding shares as of December 31, 2023. Digital sales4 reached $9.6 billion, with digital ordering accounting for approximately 90% of total Company sales. Total membership of KFC and Pizza Hut exceeded 525 million, up 11% versus the prior year. Member sales accounted for approximately 65% of KFC and Pizza Hut's system sales in aggregate. 1 OP margin refers to operating profit as a percentage of total revenues. 2 Core operating profit is defined as operating profit adjusted for special items, further excluding items affecting comparability and the impact of F/X. The Company uses core operating profit for the purposes of evaluating the performance of its core operations. Please refer to "Reconciliation of Reported GAAP Results to Non-GAAP Measures" included in the accompanying tables of this release for further details. 3 Net new unit contribution refers to sales contribution from net new stores. 4 Digital sales refer to sales at Company-owned stores where orders were placed digitally. Joey Wat, CEO of Yum China, commented, "We closed the year with a strong fourth quarter, propelling us to a number of record highs in 2024. In the fourth quarter, our system sales growth surpassed the restaurant industry's growth rate. Our same-store sales index improved sequentially to 99% of prior year levels, driven by the eighth consecutive quarter of same-store transaction growth. OP margin expanded by 140 basis points, and restaurant margin increased by 160 basis points, both on a year-over-year basis. We have steadily improved our metrics since the second quarter, with improvement in same-store sales index, margins, and operating profit growth each quarter. These results demonstrate the resilience of our business and the effectiveness of our strategy in improving sales and profitability amid challenging market conditions." Wat continued, "Our dual focus on operational efficiency and innovation yielded excellent results, laying a solid foundation for future growth. Our Project Fresh Eye and Project Red Eye initiatives have given us new perspectives on our operations and transformed our organization. They have made us more efficient, agile and competitive across our restaurants, shared service centers and supply chains. Our innovative measures—from menu evolution to the introduction of breakthrough business models like KCOFFEE Cafes and Pizza Hut WOW—have expanded our addressable market and increased our market share. KFC has demonstrated considerable resilience and growth momentum. Pizza Hut has made significant progress in transforming itself to become more affordable for customers and more profitable for the Company." Wat concluded, "Looking ahead, we remain excited about the significant growth opportunities in China. With tailored store models, we are expanding through both Company-owned stores and franchise stores and are on track to achieve our goal of 20,000 stores by 2026. Franchisees enable us to expand into remote areas, lower-tier cities and strategic locations previously beyond our reach. We are also increasing our cash dividend by a considerable 50% and continuing our share repurchases, positioning us to return a total of $4.5 billion to shareholders between 2024 and 2026. The average annual amount is equivalent to 9% of our current market capitalization. Leveraging our unique strengths, we are confident the steps we are taking will help create sustainable long-term value for our shareholders." Key Financial Results Fourth Quarter Full Year %/ppts Change %/ppts Change 2024 2023 Reported Ex F/X 2024 2023 Reported Ex F/X System Sales Growth (5) (%) 4 21 NM NM 5 21 NM NM Same-Store Sales Growth (5) (%) (1) 4 NM NM (3) 7 NM NM Operating Profit ($mn) 151 110 +36 +35 1,162 1,106 +5 +8 Adjusted Operating Profit (6) ($mn) 151 116 +29 +28 1,162 1,121 +4 +6 Core Operating Profit (6) (7) ($mn) 150 110 NM +35 1,190 1,061 NM +12 OP Margin (%) 5.8 4.4 +1.4 +1.4 10.3 10.1 +0.2 +0.3 Core OP Margin (6) (8) (%) 5.8 4.4 NM +1.4 10.4 9.7 NM +0.7 Net Income ($mn) 115 97 +18 +17 911 827 +10 +13 Adjusted Net Income (6) ($mn) 115 103 +11 +10 911 842 +8 +11 Diluted Earnings Per Common Share ($) 0.30 0.23 +30 +27 2.33 1.97 +18 +22 Adjusted Diluted Earnings Per Common Share (6) ($) 0.30 0.25 +20 +20 2.33 2.00 +17 +19 5 System sales and same-store sales percentages exclude the impact of F/X. Effective January 1, 2018, temporary store closures are normalized in the same-store sales calculation by excluding the period during which stores are temporarily closed. 6 See "Reconciliation of Reported GAAP Results to non-GAAP Measures" included in the accompanying tables of this release for further details. 7 Current period amounts are derived by translating results at average exchange rates of the prior year period. 8 Core OP margin refers to core operating profit as a percentage of total revenues excluding F/X. Note: All comparisons are versus the same period a year ago. Percentages may not recompute due to rounding. NM refers to not meaningful. Capital Returns to Shareholders The Company is on track to return a total of $4.5 billion to shareholders between 2024 and 2026. o The Company returned $1.5 billion in capital to shareholders for the full year and $248 million in the fourth quarter. o For the full year, Yum China repurchased 31.3 million shares of common stock, which is equivalent to approximately 8% of its outstanding shares as of December 31, 2023. o As of December 31, 2024, approximately $1.3 billion remained available for future share repurchases under the current authorization program. The Company plans to return a total of $3 billion to shareholders from the beginning of 2025 through the end of 2026. o The Board declared a 50% increase in the cash dividend, raising it to $0.24 per share on Yum China's common stock, payable on March 27, 2025, to shareholders of record as of the close of business on March 6, 2025. o The Company has entered into share repurchase agreements in the U.S. and Hong Kong for an aggregate repurchase amount of approximately US$360 million through open market transactions for the first half of 2025. The share repurchase agreements include approximately US$290 million under Rule 10b5-1 of the U.S. Securities Exchange Act of 1934 in the U.S. and approximately HK$550 million for a similar program in Hong Kong. KFC Fourth Quarter Full Year %/ppts Change %/ppts Change 2024 2023 Reported Ex F/X 2024 2023 Reported Ex F/X Restaurants 11,648 10,296 +13 NM 11,648 10,296 +13 NM System Sales Growth (%) 5 20 NM NM 6 20 NM NM Same-Store Sales Growth (%) (1) 3 NM NM (2) 7 NM NM Total Revenues ($mn) 1,954 1,872 +4 +4 8,509 8,240 +3 +5 Operating Profit ($mn) 192 167 +15 +15 1,192 1,202 (1) +2 Core Operating Profit ($mn) 191 162 NM +18 1,218 1,154 NM +6 OP Margin (%) 9.9 8.9 +1.0 +1.0 14.0 14.6 (0.6) (0.5) Restaurant Margin (%) 13.3 12.0 +1.3 +1.3 16.9 17.7 (0.8) (0.8) Fourth Quarter: System sales for KFC grew 5% YoY. Same-store sales reached 99% of the prior year's level, improved from 98% in the third quarter. Same-store transactions grew 3% YoY, the eighth consecutive quarter of growth. Delivery sales grew 16% YoY, contributing approximately 42% of KFC's Company sales. Operating profit increased 15% and Core operating profit increased 18% YoY. OP margin was 9.9%, an increase of 100 basis points YoY. Restaurant margin was 13.3%. Excluding items affecting comparability at the restaurant level, restaurant margin expanded 160 basis points YoY, primarily due to favorable commodity prices and higher operational efficiency, partially offset by the impact of increased value-for-money offerings and wage inflation. Full Year: System sales for KFC grew 6% YoY. Same-store sales reached 98% of the prior year's level. Delivery sales grew 16%, contributing approximately 40% of KFC's Company sales. KFC opened a record 1,352 net new stores in 2024, with 402 net new stores opened by franchisees, accounting for 30%. Total store count reached 11,648 stores at year-end 2024, of which 13% are operated by franchisees. Operating profit was $1.2 billion, a 1% decrease YoY. Core operating profit increased 6%. OP margin was 14.0%. Restaurant margin was 16.9%. Excluding items affecting comparability at the restaurant level, restaurant margin decreased by 20 basis points, primarily due to increased value-for-money offerings to drive traffic and wage inflation, partially offset by favorable commodity prices and improved operational efficiency. Pizza Hut Fourth Quarter Full Year %/ppts Change %/ppts Change 2024 2023 Reported Ex F/X 2024 2023 Reported Ex F/X Restaurants 3,724 3,312 +12
Autohome Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
BEIJING, Feb. 6, 2025 /PRNewswire/ -- Autohome Inc. (NYSE: ATHM; HKEX: 2518) ("Autohome" or the "Company"), a leading online destination for automobile consumers in China, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2024, before U.S. markets open on February 20, 2025. Autohome's management team will host an earnings conference call at 7:00 AM U.S. Eastern Time on Thursday, February 20, 2025 (8:00 PM Beijing Time on the same day). Please register in advance of the conference using the registration link provided below. Upon registering, each participant will receive a set of participant dial-in numbers and a personal PIN, which will be used to join the conference call. Details for the conference call are as follows: Event Title: Q4 and Full Year 2024 Autohome Inc Earnings Conference Call Registration Link: https://register.vevent.com/register/BI255a7f8360974da5ae7ffaf90252fa85 Please use the conference access information to join the call ten minutes before the call is scheduled to begin. Additionally, a live and archived webcast of the conference call will be available at http://ir.autohome.com.cn and a replay of the webcast will be available following the session. About Autohome Inc. Autohome Inc. (NYSE: ATHM; HKEX: 2518) is the leading online destination for automobile consumers in China. Its mission is to engage, educate and inform consumers about everything auto. Autohome provides occupationally-generated content, professionally-generated content, user-generated content, and AI-generated content, a comprehensive automobile library, and extensive automobile listing information to automobile consumers, covering the entire car purchase and ownership cycle. The ability to reach a large and engaged user base of automobile consumers has made Autohome a preferred platform for automakers and dealers to conduct their advertising campaigns. Further, the Company's dealer subscription and advertising services allow dealers to market their inventory and services through Autohome's platform, extending the reach of their physical showrooms to potentially millions of internet users in China and generating sales leads for them. The Company offers sales leads, data analysis, and marketing services to assist automakers and dealers with improving their efficiency and facilitating transactions. Autohome operates its "Autohome Mall," a full-service online transaction platform, to facilitate transactions for automakers and dealers. Further, through its websites and mobile applications, it also provides other value-added services, including auto financing, auto insurance, used car transactions, and aftermarket services. For further information, please visit www.autohome.com.cn. For investor and media inquiries, please contact: In China: Autohome Inc.Investor Relations Sterling SongInvestor Relations DirectorTel: +86-10-5985-7483E-mail: ir@autohome.com.cn Christensen China Limited Suri ChengTel: +86-185-0060-8364E-mail: suri.cheng@christensencomms.com
The View From the World's Largest Humanitarian Aid Hub - Dubai Humanitarian: Children Suffered Most From Global Crises in 2024
- Over $137m of aid distributed to 106 countries from Dubai Humanitarian aid hub used by international organisations including UNICEF, IFRC, WHO and WFP FULL RELEASE CAN BE DOWNLOADED HERE DUBAI, UAE, Feb. 6, 2025 /PRNewswire/ -- Dubai Humanitarian, the world's largest humanitarian aid hub, leading efforts to provide aid to those affected by the crisis in Gaza, has released data from the Humanitarian Logistics Databank that reveals more than $137million worth of humanitarian aid was distributed to 106 countries during 2024. 21 September 2024 – Dubai Humanitarian Loading Aid 2024 was marked by significant global crises, with the data demonstrating the heavy impact that conflicts and natural disasters have had on children. Underreported crises in Yemen, Pakistan, and some African nations have led to a quadrupling of children's food aid to $19.6million and a tripling of education aid to $1.2million. 2024 in numbers Health Aid: Nearly one-third of the aid, more than $40million, was dedicated to health. Food Security Aid: The demand for food security products saw a dramatic increase, quadrupling from $5million in 2023 to $19.6million in 2024. This included 54.6million sachets of food supplements suitable for children from six months old. Education Aid: There was an almost quadrupling in the demand for education aid, which increased from $320,000 in 2023 to more than $1.2million in 2024. Shelter Aid: Almost one-third of the aid, totalling $31.7million, was allocated to shelter. Water and Sanitation Aid: The demand for water and sanitation aid remained consistent with 2023 levels, amounting to $3.2million. Giuseppe Saba, CEO, Dubai Humanitarian, commented: "2024 was a year of unprecedented challenges for the world. From our Humanitarian Logistics Databank data we can see that it is children that were most affected. With our UN partners and other humanitarian members, in 2024 we supported the distribution of more than $137million of aid to countries across the world, but the enormous impact on the nutrition and education of children has been particularly striking." Walid Ibrahim, UNHRD Network Coordinator, added: "Through partnerships with over 22 organizations, the UN Humanitarian Response Depot, operated by WFP, mobilised and delivered critical lifesaving support to major emergencies including Afghanistan, Gaza, Lebanon, and Yemen, as well as to ongoing operations in 65 countries worldwide in 2024. This significant achievement was the result of ongoing anticipatory action, team collaboration, and the vital commitment and support of our strategic partners Dubai Humanitarian and the UAE Government in ensuring timely aid is deployed to vulnerable communities when they need it most." The Humanitarian Logistics Databank was launched by Dubai Humanitarian in 2018 as a centralised platform designed to enhance the humanitarian community's emergency preparedness and response by providing real-time data on humanitarian aid stocks and flows. Photo: https://mma.prnasia.com/media2/2613427/Dubai_Humanitarian.jpg?p=medium600Photo: https://mma.prnasia.com/media2/2613428/Dubai_Humanitarian.jpg?p=medium600 (L-R) Dubai Humanitarian CEO Giuseppe Saba with UNHRD Coordinator, Walid Ibrahim